We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Supernus Pharmaceuticals
SUPN
$2.77B
| $4.95M | 0.01% |
164,578
-9,388
| -5% | -$329K |
|
1377
Western Alliance Bancorporation
WAL
$8.87B
| $4.94M | 0.01% |
135,375
+3,534
| +3% | +$123K |
|
1378
Vale
VALE
$62.6B
| $4.93M | 0.01% |
+367,726
| New | +$5.21M |
|
|
PGTI
1379
DELISTED
PGT, Inc.
PGTI
| $4.93M | 0.01% |
169,207
-1,397
| -0.8% | -$36.8K |
|
|
HBI
1380
DELISTED
Hanesbrands
HBI
| $4.93M | 0.01% |
1,085,395
+107,810
| +11% | +$493K |
|
1381
Tennant Co
TNC
$1.26B
| $4.91M | 0.01% |
60,574
-1,475
| -2% | -$111K |
|
1382
Evolent Health
EVH
$444M
| $4.91M | 0.01% |
162,032
+44,112
| +37% | +$1.43M |
|
1383
Strategic Education
STRA
$1.92B
| $4.9M | 0.01% |
72,194
-1,641
| -2% | -$134K |
|
|
RETA
1384
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.9M | 0.01% |
48,033
+7,625
| +19% | +$722K |
|
1385
Photronics
PLAB
$1.93B
| $4.89M | 0.01% |
189,799
+8,839
| +5% | +$164K |
|
1386
Teladoc Health
TDOC
$1.3B
| $4.89M | 0.01% |
193,283
+7,063
| +4% | +$178K |
|
1387
Upbound Group
UPBD
$1.16B
| $4.89M | 0.01% |
157,175
+2,936
| +2% | +$85.8K |
|
1388
Oxford Industries
OXM
$552M
| $4.88M | 0.01% |
49,567
+202
| +0.4% | +$20.7K |
|
1389
Archrock
AROC
$5.8B
| $4.88M | 0.01% |
475,648
-7,159
| -1% | -$70.6K |
|
1390
Green Brick Partners
GRBK
$3.14B
| $4.86M | 0.01% |
85,578
-831
| -1% | -$38.7K |
|
1391
Par Pacific Holdings
PARR
$3.32B
| $4.85M | 0.01% |
182,358
+13,332
| +8% | +$315K |
|
|
NEWR
1392
DELISTED
New Relic, Inc.
NEWR
| $4.85M | 0.01% |
74,110
+7,852
| +12% | +$566K |
|
1393
John Wiley & Sons Class A
WLY
$2.66B
| $4.85M | 0.01% |
142,475
-2,259
| -2% | -$82.3K |
|
1394
StoneX
SNEX
$7.94B
| $4.84M | 0.01% |
294,774
-4,531
| -2% | -$80.8K |
|
1395
Ironwood Pharmaceuticals
IRWD
$711M
| $4.83M | 0.01% |
454,301
+38,476
| +9% | +$414K |
|
|
VGR
1396
DELISTED
Vector Group Ltd.
VGR
| $4.83M | 0.01% |
376,936
+19,843
| +6% | +$245K |
|
1397
AXIS Capital
AXS
$7.55B
| $4.8M | 0.01% |
89,205
+5,793
| +7% | +$317K |
|
|
AL
1398
DELISTED
Air Lease Corp
AL
| $4.8M | 0.01% |
114,711
+2,531
| +2% | +$100K |
|
1399
POSCO
PKX
$17.5B
| $4.8M | 0.01% |
+64,861
| New | +$4.72M |
|
|
ALEX
1400
DELISTED
Alexander & Baldwin
ALEX
| $4.8M | 0.01% |
258,089
+3,701
| +1% | +$69.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.